Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

15.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Prodrugs01:30

Prodrugs

3.0K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of Ligands for the TNFR1 Extracellular Domain Using Fragment-Based Drug Discovery.

ChemMedChem·2026
Same author

Oral Delivery of Mesenchymal Stem Cell-Derived Extracellular Vesicles To Treat Intestinal Inflammation.

ACS applied materials & interfaces·2026
Same author

Neuroendocrine tumors and pregnancy: the French PregNET study.

European journal of endocrinology·2026
Same author

Engineering perfusion to meet tumor biology: are vascularized tumor-on-a-chip models ready to drive therapy innovation?

Lab on a chip·2026
Same author

Millennial-scale societal shifts drive the widespread loss of oyster reefs in East Asia.

Current biology : CB·2025
Same author

Predictive imaging in abdominal oncology: current trends and future directions.

Japanese journal of radiology·2025

Related Experiment Video

Updated: Sep 16, 2025

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
08:54

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

1.2K

A Targeted Redox-Active Dual-Action Pt(IV)-Mn(II) Prodrug Displays Enhanced In Vivo Anticancer Activity.

Alvaro Lopez-Sanchez1, Henri Chédotal1, Ram Pravin Kumar Muthuramalingam2

  • 1Laboratoire Chimie Physique et Chimie du Vivant CPCV, Département de chimie, Ecole normale supérieure, PSL University, Sorbonne Université, CNRS, 24 rue Lhomond, Paris, 75005, France.

Advanced Healthcare Materials
|July 7, 2025
PubMed
Summary

A novel platinum(IV) prodrug with a manganese superoxide dismutase mimic shows promise for colorectal cancer treatment. Encapsulation in micelles led to total tumor remission in mice, suggesting enhanced therapeutic potential.

Keywords:
SOD mimicsdrug discoverynanoformulationoxaliplatinoxidative stressplatinum prodrugs

More Related Videos

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.1K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

497

Related Experiment Videos

Last Updated: Sep 16, 2025

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
08:54

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

1.2K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.1K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

497

Area of Science:

  • Medicinal Chemistry
  • Nanotechnology
  • Oncology

Background:

  • Platinum-based chemotherapy faces challenges like drug resistance and side effects.
  • Platinum(IV) prodrugs offer a promising alternative to traditional platinum anticancer drugs.
  • Developing novel platinum(IV) prodrugs with enhanced efficacy and reduced toxicity is crucial.

Purpose of the Study:

  • To synthesize and characterize a novel bimetallic dual-action platinum(IV) prodrug.
  • To evaluate the in vitro and in vivo efficacy of the platinum(IV) prodrug in colorectal cancer models.
  • To investigate the therapeutic potential of a PEGylated micellar formulation of the platinum(IV) prodrug.

Main Methods:

  • Synthesis and characterization of a novel platinum(IV) prodrug incorporating a manganese superoxide dismutase mimic.
  • In vitro cytotoxicity assays using 2D and 3D colorectal cancer cell models.
  • In vivo efficacy studies in a colorectal cancer mouse model.
  • Evaluation of a PEGylated micellar encapsulation strategy for the prodrug.

Main Results:

  • The novel platinum(IV) prodrug exhibited high stability and intrinsic antisuperoxide properties.
  • In vitro studies showed comparable cytotoxicity to oxaliplatin with increased intracellular reactive oxygen species (ROS).
  • In vivo studies demonstrated similar efficacy to oxaliplatin, with total tumor remission achieved using the PEGylated micellar formulation.
  • The micellar formulation enhanced prodrug lifetime, tumoral uptake, and plasma content.

Conclusions:

  • The novel bimetallic platinum(IV) prodrug demonstrates significant therapeutic potential for colorectal cancer.
  • PEGylated micellar encapsulation enhances the delivery and efficacy of the platinum(IV) prodrug.
  • This formulation represents a promising strategy for overcoming chemoresistance and improving treatment outcomes.